Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

• Pietro Bulian,
• Riccardo Bomben,
• Michele Dal Bo,
• Antonella Zucchetto,
• Francesca Maria Rossi,
• Massimo Degan,
• Federico Pozzo,
• Tamara Bittolo,
• Vanessa Bravin,
• Tiziana D’Agaro,
• Michaela Cerri,
• Annalisa Chiarenza,
• Kari G. Chaffee,
• Adalgisa Condoluci,
• Giovanni D’Arena,
• Michele Spina,
• Francesco Zaja,
• Gabriele Pozzato,
• Francesco Di Raimondo,
• Davide Rossi,
• Giovanni Del Poeta,
• Gianluca Gaidano,
• Tait D. Shanafelt,
• Valter Gattei

Affiliations

Pietro Bulian

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Riccardo Bomben

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Michele Dal Bo

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Antonella Zucchetto

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Francesca Maria Rossi

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Massimo Degan

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Federico Pozzo

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Tamara Bittolo

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Vanessa Bravin

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Tiziana D’Agaro

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy

Michaela Cerri

Division of Hematology – Department of Translational Medicine – Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Annalisa Chiarenza

Division of Hematology, Ferrarotto Hospital, Catania, Italy

Kari G. Chaffee

Department of Hematology, Mayo Clinic, Rochester, MN, USA

Adalgisa Condoluci

Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland

Giovanni D’Arena

IRCCS, Referral Cancer Center of Basilicata, Potenza, Italy

Michele Spina

Oncologia Medica A IRCCS, Centro di Riferimento Oncologico, Aviano, Italy

Francesco Zaja

Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy

Gabriele Pozzato

Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy

Francesco Di Raimondo

Division of Hematology, Ferrarotto Hospital, Catania, Italy

Davide Rossi

Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland

Giovanni Del Poeta

Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy

Gianluca Gaidano

Division of Hematology – Department of Translational Medicine – Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Tait D. Shanafelt

Department of Hematology, Mayo Clinic, Rochester, MN, USA

Valter Gattei

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy